Skip to content
  1. Research

Publications

Take a look at CHIBE’s publications, which are helping advance the science of using behavioral economics to improve health and leading to discoveries around how our minds work.

Reasons for and Outcomes of Medicare Part D Appeals for Denied GLP-1 Receptor Agonist Claims

Diabetes, Obesity and Metabolism
August 10, 2026
Matthew J. Klebanoff, John C. Lin, Judith A. Long, Eric Bressman, Jalpa A. Doshi

PCSK9 Inhibitor Price Reductions and Medicare Part D Utilization and Spending

JAMA Cardiology
July 1, 2026
Jalpa A. Doshi, Matthew J. Klebanoff, Maya Merchant, Pengxiang Li, Dhruv S. Kazi

Real-World Overall Survival and Time to Next Treatment Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Frontline Setting

Cancers
June 3, 2026
Scott F Huntington, Justin T Puckett, Beenish S Manzoor, Nnadozie Emechebe, Sophia S Li Sachin Kamal-Bahl, Carolina Reyes, Holly Budlong, Jalpa A Doshi

Identifying Meaningful Patient Savings on Generics: Direct-to-Consumer Prices Versus Commercial Insurance Cost Sharing

Annals of Internal Medicine
May 26, 2026
John K. Lin, Jenny J. Xiang, Xiudong Lei, Sunita Desai, Erin Trish, Fumiko Chino, Meng Li, Sharon H. Giordano, Ying Xu, Changchuan Jiang, Jalpa A. Doshi, Ya-Chen Tina Shih

Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis

JAMA Health Forum
April 24, 2026
Pengxiang Li; Matthew J. Klebanoff; John K. Lin; Keya D. Doshi; Salim Chahin; Jalpa A. Doshi

HSR26-253: Patient Assistance for Drug Cost Sharing: Highlighting the Variability Across Pharmaceutical Manufacturers of Specialty Oral Anticancer Medications for Blood Cancers

JNJCCN
March 31, 2026
Anoosha Shukla, John K. Lin, Pengxiang Li, Scott F. Huntington, and Jalpa A. Doshi

Specialty Oral Anticancer Prescription Fill Rates After Medicare Part D Cost-Sharing Changes in 2024

JAMA Network
December 29, 2025
John K Lin, Pengxiang Li, Xiudong Lei, Sunita M Desai, Jalpa A Doshi

CAR-T for all? Barriers, facilitators, and interventions to commercial CAR T-cell therapy access

Blood Reviews
December 16, 2025
Sofia Kaparis, Khashayar Eshaghi, Luca Paruzzo, Jalpa Doshi, Marco Ruella, Carmen E Guerra

Medicaid Coverage and Prior Authorization for Antiobesity Glucagon-Like Peptide-1 Receptor Agonists: A Cross-Sectional Study of State Policies

Journal of General Internal Medicine
November 21, 2025
Matthew J Klebanoff, Ashwin K Chetty, Jalpa A Doshi

Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists

JAMA
September 24, 2025
Matthew J. Klebanoff, Pengxiang Li, Judith A. Long, Jalpa A. Doshi

Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis

Neurology Clinical Practice
September 16, 2025
Pengxiang Li, John K Lin, Matthew J Klebanoff, Riya Palkar, Salim Chahin, Jalpa A Doshi

Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers

Journal of Clinical Oncology
August 27, 2025
John K Lin, Jiangong Niu, Sharon H Giordano, Pengxiang Li, Rebecca A Snyder, Kaiping Liao, Meng Li, Ana Aparicio, William Chapin, Jianjun Zhang, Jenny Xiang, Nirosha Perera, Debanjan Pain, Carmen E Guerra, Jalpa A Doshi

Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs

JAMA Health Forum
May 16, 2025
Jalpa A Doshi, Pengxiang Li, Matthew J Klebanoff, John K Lin

Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan

JCO Oncology Practice
April 25, 2025
Jalpa A Doshi, Pengxiang Li, Shravan Asthana, John K Lin

Opioid Cap Laws and Opioid Prescriptions After Total Joint Replacements in Older Adults

JAMA Network Open
April 9, 2025
Caroline P Thirukumaran, Derek T Schloemann, Jalpa A Doshi, Kevin A Fiscella, Benjamin F Ricciardi, Meredith B Rosenthal

Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia

Advances in Therapy
January 15, 2025
Pengxiang Li, Zhi Geng, Carmela Benson, Charmi Patel, Jalpa A Doshi